Goldman Sachs
BNTX icon

Goldman Sachs’s BioNTech BNTX Stock Holding History

Goldman Sachs’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,900
Closed -$2.08M – 6499
2025
Q4 		$2.08M Buy
21,900
+900
+4% +$90.7K ﹤0.01% 4549
2025
Q3 		$2.07M Hold
21,000
– – ﹤0.01% 4444
2025
Q2 		$2.24M Sell
21,000
-16,900
-45% -$1.71M ﹤0.01% 4091
2025
Q1 		$3.45M Buy
37,900
+4,900
+15% +$549K ﹤0.01% 3708
2024
Q4 		$3.76M Hold
33,000
– – ﹤0.01% 3740
2024
Q3 		$3.92M Buy
33,000
+16,000
+94% +$1.47M ﹤0.01% 3567
2024
Q2 		$1.37M Buy
17,000
+11,100
+188% +$1.01M ﹤0.01% 4235
2024
Q1 		$544K Buy
+5,900
New +$566K ﹤0.01% 4711
2023
Q3 		– Sell
-20,000
Closed -$2.16M – 5555
2023
Q2 		$2.16M Hold
20,000
– – ﹤0.01% 3824
2023
Q1 		$2.49M Buy
20,000
+17,200
+614% +$2.36M ﹤0.01% 3695
2022
Q4 		$421K Hold
2,800
– – ﹤0.01% 4964
2022
Q3 		$378K Hold
2,800
– – ﹤0.01% 5158
2022
Q2 		$417K Sell
2,800
-182,800
-98% -$27.9M ﹤0.01% 5210
2022
Q1 		$31.7M Buy
185,600
+81,500
+78% +$13.7M 0.01% 1679
2021
Q4 		$26.8M Buy
104,100
+74,100
+247% +$20.3M 0.01% 1861
2021
Q3 		$8.19M Sell
30,000
-82,500
-73% -$26.2M ﹤0.01% 2915
2021
Q2 		$25.2M Buy
112,500
+102,800
+1,060% +$19.4M 0.01% 1847
2021
Q1 		$1.06M Buy
+9,700
New +$1.03M ﹤0.01% 4569
2020
Q4 		– Sell
-134,500
Closed -$9.31M – 5490
2020
Q3 		$9.31M Buy
+134,500
New +$9.65M ﹤0.01% 2390

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs's BNTX Position: Q1 2026 in Review

Goldman Sachs reduced its BioNTech (BNTX) stake by 11% in Q1 2026, selling an estimated $1.17M and leaving 96,829 shares worth $8.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3191.

Goldman Sachs first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $84.7M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Goldman Sachs held 96,829 shares of BioNTech worth $8.61M as of Q1 2026.
  • Goldman Sachs sold 11,417 BioNTech shares in Q1 2026, an estimated $1.17M.
  • BioNTech made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3191 holding.
  • Goldman Sachs first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Goldman Sachs's BioNTech position peaked at $84.7M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.